EGFR and acute respiratory distress syndrome: Treatment with EGFR inhibitors, such as erlotinib, AG1478, and 451 effectively reduced inflammatory cell infiltration and relieved lung injury in the ALI animal models (Shan et al., 2017; Tao et al., 2019).